Investors who lost money with shares of Exscientia plc (NASDAQ: EXAI) should contact the Shareholders Foundation in connection with pending Lawsuit

An investor, who purchased shares of Exscientia plc (NASDAQ: EXAI), filed a lawsuit over alleged violations of Federal Securities Laws by Exscientia plc in connection with certain allegedly false and misleading statements.

If you purchased a significant amount of shares of Exscientia plc (NASDAQ: EXAI), you have certain options and for certain investors are short and strict deadlines running. Deadline: June 25, 2024. NASDAQ: EXAI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

United Kingdom based Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. On February 13, 2024, Exscientia plc announced the termination of Andrew Hopkins as the company's Chief Executive Officer and Principal Executive Officer, as well as his removal as an Executive Director of the Board, effective immediately and for cause. This decision by the Board of Directors was made following an investigation that revealed Dr. Hopkins had engaged in inappropriate relationships with two employees, which were deemed inconsistent with the company's standards and values.
Further details emerged as a special committee of the board enlisted outside counsel to investigate the alleged conduct of the executive. The inquiry uncovered, per news reports, that David Nicholson, the board chairman, had prior knowledge of one of Hopkins' relationships and addressed it independently with outside counsel, rather than consulting with the board. Subsequently, after discussions with other board members, Nicholson resigned from his board position.

Shares of Exscientia plc (NASDAQ: EXAI) declined from $7.91 per share on February 12, 2024, to $4.33 per share on April 15, 2024.

The plaintiff claims that between March 23, 2022, and February 12, 2024, the Defendants made false and/or misleading statements and/or failed to disclose that Defendant Hopkins had engaged in improper relationships with employees that were inconsistent with the Company's standards and values, that Defendant Nicholson had prior knowledge of Defendant Hopkins's relationships and had improperly addressed Hopkins's misconduct without consulting the Board, that the Company's maintenance and enforcement of its Code of Business Conduct and Ethics was inadequate to safeguard against the foregoing conduct, that the foregoing failures subjected the Company to a heightened risk of disruptive leadership transitions and/or reputational harm, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of Exscientia plc (NASDAQ: EXAI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.